Review decisions
Showing 210 results of 633 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1692037182503
Product Type: Drug
Control Number: 234666
DIN(s): 02245619, 02456915, 02512173
Manufacturer: Teva Canada Limited
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-12-23
Decision / Authorization Date: 2021-02-04
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1692291386055
Product Type: Drug
Control Number: 237401
DIN(s): 02145901, 02514435
Manufacturer: Sandoz Canada Incorporated
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-20
Decision / Authorization Date: 2021-04-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1694610519770
Product Type: Drug
Control Number: 241747
Manufacturer: Boehringer Ingelheim (Canada) Ltd Ltee
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-07-16
Decision / Authorization Date: 2021-06-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01054
Product Type: Drug
Control Number: 265333
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-06-17
Decision / Authorization Date: 2023-01-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01053
Product Type: Drug
Control Number: 241617
Manufacturer: ALK-Abello A/S
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-07-10
Decision / Authorization Date: 2022-12-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01048
Product Type: Drug
Control Number: 260018
DIN(s): 02533472, 02533480
Manufacturer: Samsung Bioepis Co., Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-12-31
Decision / Authorization Date: 2022-12-14
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01058
Product Type: Drug
Control Number: 262060
DIN(s): 02533448, 02533456
Manufacturer: Alexion Pharma GmbH
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-04
Decision / Authorization Date: 2022-12-13
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01049
Product Type: Drug
Control Number: 259880
Manufacturer: Janssen Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-12-31
Decision / Authorization Date: 2022-12-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01038
Product Type: Drug
Control Number: 259754
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-12-17
Decision / Authorization Date: 2022-11-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01045
Product Type: Drug
Control Number: 259175
DIN(s): 02453304
Manufacturer: Horizon Therapeutics Ireland DAC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-12-01
Decision / Authorization Date: 2022-11-24